Translational Pathways for Cardiovascular Devices – Session IV: Clinical Need for Innovative Coronary Stent – Gregg Stone Practice Quiz
Quiz Summary
0 of 7 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
Time has elapsed
Categories
- Not categorized 0%
You have completed the practice quiz, please continue on to the next session.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Current
- Review
- Answered
- Correct
- Incorrect
- Question 1 of 7
1. Question
What are the approximate bare metal stent (BMS) restenosis rates?
CorrectIncorrect - Question 2 of 7
2. Question
Which of the following is correct regarding the drug-eluting stent?
CorrectIncorrect - Question 3 of 7
3. Question
Which of the following is correct regarding stent thrombosis (ST)?
CorrectIncorrect - Question 4 of 7
4. Question
The results of the SYNTAX trial showed an occurrence of 5 year definite or probable stent thrombosis in patients with multivessel disease to be?
CorrectIncorrect - Question 5 of 7
5. Question
In the FAME trial, that compared FFR-guided vs. angiography-guided intervention, what was the absolute difference in cardiovascular events?
CorrectIncorrect - Question 6 of 7
6. Question
The reason for reduced stent thrombosis in second generation drug-eluting stents (DES) compared to first generation (DES) is?
CorrectIncorrect - Question 7 of 7
7. Question
Which of the following is correct regarding Polymer free metallic stents?
CorrectIncorrect